Does Current Oral Antiplatelet Agent or Subtherapeutic Anticoagulation Use Have an Effect on Tissue-Plasminogen-Activator-Mediated Recanalization Rate in Patients with Acute Ischemic Stroke?

Publisher： Karger

E-ISSN： 1421-9786|30|5|508-513

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.30, Iss.5, 2010-09, pp. : 508-513

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recanalization within One Hour after Intravenous Tissue Plasminogen Activator Is Associated with Favorable Outcome in Acute Stroke Patients

By  

European Neurology, Vol. 63, Iss. 6, 2010-06 ,pp. : 331-336

Karger

Access to resources Recommend Favorite

Does ICA Occlusion Frequently Have Intracerebral Hemorrhage after IV Tissue Plasminogen Activator Therapy for Ischemic Stroke?

By  

European Neurology, Vol. 65, Iss. 5, 2011-04 ,pp. : 245-249

Karger

Access to resources Recommend Favorite

Repeated Intravenous Treatment with Recombinant Tissue-Type Plasminogen Activator in Patients with Acute Ischemic Stroke

By  

European Neurology, Vol. 74, Iss. 3-4, 2015-09 ,pp. : 127-134

Karger

Access to resources Recommend Favorite

Eligibility for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 22, Iss. 5-6, 2006-11 ,pp. : 423-428

Karger

Access to resources Recommend Favorite

Low-Dose Tissue Plasminogen Activator and Standard-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke in Asian Populations: A Review

By  

Cerebrovascular Diseases, Vol. 36, Iss. 3, 2013-10 ,pp. : 161-166

Karger

Access to resources Recommend Favorite